Drug Shortage Report for PMS-ERLOTINIB
Report ID | 6123 |
Drug Identification Number | 02454386 |
Brand name | PMS-ERLOTINIB |
Common or Proper name | ERLOTINIB |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | ERLOTINIB |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | L01XE |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2017-07-14 |
Actual start date | 2017-07-14 |
Estimated end date | Unknown |
Actual end date | 2018-05-04 |
Shortage status | Resolved |
Updated date | 2018-05-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2018-05-05 | English | Compare |
v12 | 2018-05-04 | French | Compare |
v11 | 2018-05-04 | English | Compare |
v10 | 2017-10-11 | French | Compare |
v9 | 2017-10-11 | English | Compare |
v8 | 2017-07-15 | English | Compare |
v7 | 2017-06-23 | French | Compare |
v6 | 2017-06-23 | English | Compare |
v5 | 2017-06-16 | French | Compare |
v4 | 2017-06-16 | English | Compare |
v3 | 2017-04-29 | English | Compare |
v2 | 2017-04-07 | French | Compare |
v1 | 2017-04-07 | English | Compare |
Showing 1 to 13 of 13